These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31556374)

  • 1. Medicare's Evolution: National Pharmacare and Shared Leadership.
    Nemis-White J; Torr E; Aylen J; Gogovor A; Martin L; Mitchell J; MacPherson N; Montague T
    Healthc Q; 2019 Jul; 22(2):15-19. PubMed ID: 31556374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare in Canada: Choices Going Forward.
    Montague T; Cochrane B; Gogovor A; Aylen J; Martin L; Nemis-White J
    Healthc Q; 2018 Apr; 21(1):13-18. PubMed ID: 30051810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Adherence to Prescribed Therapies: Pharmacare's Existential Challenge.
    Gogovor A; Nemis-White J; Torr E; MacPherson N; Martin L; Aylen J; Manness LJ; Montague T
    Healthc Q; 2019 Jul; 22(2):21-26. PubMed ID: 31556375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canada's Evolving Medicare: Patient-Centred Care.
    Montague T; Nemis-White J; Aylen J; Torr E; Martin L; Gogovor A
    Healthc Q; 2019 Jul; 22(2):27-31. PubMed ID: 31556376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for Best Direction in Healthcare: Distilling Opportunities, Priorities and Responsibilities.
    Montague T; Gogovor A; Marshall L; Cochrane B; Ahmed S; Torr E; Aylen J; Nemis-White J
    Healthc Q; 2016; 19(3):44-49. PubMed ID: 27808023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy choices for pharmacare; the need to examine benefit design, medication management strategies and evaluation.
    Sketris IS; Brown MG; Murphy AL
    Healthc Pap; 2004; 4(3):36-45; discussion 68-72. PubMed ID: 15114068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Centred Care in Canada: Key Components and the Path Forward.
    Montague T; Gogovor A; Aylen J; Ashley L; Ahmed S; Martin L; Cochrane B; Adams O; Nemis-White J
    Healthc Q; 2017; 20(1):50-56. PubMed ID: 28550701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. It's Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada".
    Lexchin J
    Int J Health Policy Manag; 2020 Dec; 9(12):528-530. PubMed ID: 32610770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It Won't Be Easy: How to Make Universal Pharmacare Work in Canada.
    Lewis S
    Int J Health Policy Manag; 2020 Jan; 9(1):1-5. PubMed ID: 31902189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Pharmacare in Canada".
    Acri Née Lybecker KML
    Int J Health Policy Manag; 2021 Mar; 10(3):152-154. PubMed ID: 32610780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards universal coverage: a policy analysis of the development of the National Health Insurance Scheme in Nigeria.
    Onoka CA; Hanson K; Hanefeld J
    Health Policy Plan; 2015 Nov; 30(9):1105-17. PubMed ID: 25339634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal prescription drug coverage in Canada: Long-promised yet undelivered.
    Morgan SG; Boothe K
    Healthc Manage Forum; 2016 Nov; 29(6):247-254. PubMed ID: 27744279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research to Action: an evaluation.
    Murphy GT; Alder R; MacKenzie A; Cook A; Maddalena V
    Nurs Leadersh (Tor Ont); 2012 Mar; 25 Spec No 2012():21-32. PubMed ID: 22398474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare".
    Rawson NSB
    Int J Health Policy Manag; 2020 Dec; 9(12):524-527. PubMed ID: 32610769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six Myths About Pharmacare.
    Lexchin J
    Health Law Can; 2017 Feb; 37(2-3):44-51. PubMed ID: 30005520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whither seniors' pharmacare: lessons from (and for) Canada.
    Morgan SG; Barer ML; Agnew JD
    Health Aff (Millwood); 2003; 22(3):49-59. PubMed ID: 12757272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public preferences for government spending in Canada.
    Ramji S; Quiñonez C
    Int J Equity Health; 2012 Oct; 11():64. PubMed ID: 23110682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health System Leadership and the Federal Role in Canada.
    Marchildon GP
    Healthc Pap; 2014; 14(3):33-8. PubMed ID: 26187563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Romanow pharmacare: last-dollar first...first-dollar lost?
    Morgan SG; Willison DJ
    Healthc Pap; 2004; 4(3):10-20. PubMed ID: 15114064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public and Professional Insights on End-of-Life Care: Results of the 2016 Health Care in Canada Survey.
    Montague T; Nemis-White J; Aylen J; Ahmed S; Baxter S; Martin L; Adams O; Gogovor A
    Healthc Q; 2017; 20(2):18-21. PubMed ID: 28837009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.